Latest Premenstrual syndrome Stories
WAYNE, N.J., April 21, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. is aware of two studies published today in The British Medical Journal, ONLINE FIRST.
WAYNE, N.J., March 25, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
A pill containing a mix of essential oils has been shown to significantly reduce the symptoms of premenstrual syndrome (PMS).
LOS ANGELES, Dec. 23, 2010 /PRNewswire/ -- In a world where millions suffer daily from the debilitating pain of migraine headaches, one name stands out as the definitive leader in natural, safe and effective treatment.
WAYNE, N.J., Sept. 24 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), Beyaz((TM)) (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets).
WAYNE, N.J., June 17 /PRNewswire/ -- In a June 16, 2010 proceeding before Judge Virginia Kendall in US Federal Court in the Northern District of Illinois, Teva Pharmaceuticals USA Inc.
WAYNE, N.J., June 15 /PRNewswire/ -- Today, Bayer HealthCare Pharmaceuticals Inc. and Bayer Schering Pharma AG sued Teva Pharmaceuticals USA, Inc., Barr Pharmaceuticals LLC, and Barr Laboratories, Inc.
OJAI, Calif., Feb. 9 /PRNewswire/ -- Vescent Labs Inc., based in Ojai, CA (http://www.vescentlabs.com), announced today that a new infomercial featuring its revolutionary all-natural dietary supplement STOP PMS will begin airing nationally in February.
All-Natural, Low-Calorie Drink Keeps Women Cool SEATTLE, Aug.
Recent studies report that women suffering severe premenstrual syndrome (PMS) who take sertraline, more commonly known as Zoloft, for 4 months face higher risks for reoccurrence than women who practice 12 month regiments of the medication.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.